(Q51918187)

English

Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs.

scientific article published in April 2006

Statements

Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit